Schedule of In Process Research and Development (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Indefinite-Lived Intangible Assets [Line Items] | |||
| Extensible enumeration not disclosed flag | false | ||
| In Process Research and Development [Member] | |||
| Indefinite-Lived Intangible Assets [Line Items] | |||
| Balance at December 31, 2024 | $ 2,260 | $ 3,017 | |
| Impairment of IPR&D | $ (757) | (757) | |
| Impairment of IPR&D | 757 | 757 | |
| Balance at December 31, 2025 | $ 2,260 | $ 2,260 | $ 2,260 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|